Vogenx, Inc. (VOGX) stock
VOGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026
$13.48−0.90 (-6.26%)
Close on Nov 17, 2026Market cap $200.25MP/E –Yield –
Vogenx price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
No price to sales ratio figures for Vogenx
Vogenx has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?